Related Experiment Video
Updated: Jun 6, 2025

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
Published on: June 10, 2022
Case Report: Alpha-Gal Diagnosis in an Adolescent With Cystic Fibrosis
Sean Coyne1, Michelle Condren2
1Pharmacy Department, The Children's Hospital at Saint Francis Hospital, Tulsa, Oklahoma, USA.
None:
A 17-year-old female with cystic fibrosis was diagnosed with alpha-gal syndrome after 6 months of progressively worsening abdominal pain. Alpha-gal is an acquired allergy to mammalian products that can impact what individuals are able to consume. This syndrome may impact an individual's ability to take medications that are animal derived or contain animal derived excipients. Through dietary removal of mammalian products, she was able to see a reduction in gastrointestinal symptoms. With the success of dietary modifications and modification of her allergy medication formulation, maintenance medication changes did not need to be made. This allowed her to continue her pre-established medication treatment plan (including exogenous pancreatic enzymes). This case highlights potential complexities in medication management of alpha-gal syndrome in an adolescent with cystic fibrosis.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Pancreatitis II: Collaborative Care
Assessment:

